发明授权
- 专利标题： Recombinant infectious laryngotracheitis virus and uses thereof
- 专利标题（中）： 重组感染性喉气管炎病毒及其用途
-
申请号： US12363134申请日： 2009-01-30
-
公开(公告)号： US07892564B2公开(公告)日： 2011-02-22
- 发明人: Martha A. Wild , Mark D. Cochran
- 申请人： Martha A. Wild , Mark D. Cochran
- 申请人地址： US NJ Summit
- 专利权人： Schering-Plough Animal Health Corp.
- 当前专利权人： Schering-Plough Animal Health Corp.
- 当前专利权人地址： US NJ Summit
- 主分类号： A61K39/245
- IPC分类号： A61K39/245
摘要：
The present invention provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene. This attenuated virus is useful as a vaccine against infectious laryngotracheitis virus.The present invention also provides a recombinant, attenuated infectious laryngotracheitis virus comprising the infectious laryngotracheitis viral genome which contains a deletion in the US2 gene, UL47-like gene, ORF4 gene or glycoprotein g60 gene.The present invention also provides a method for distinguishing chickens or other poultry vaccinated with a recombinant infectious laryngotracheitis virus which produces no glycoprotein gG from those infected with a naturally-occurring infectious laryngotracheitis virus.
公开/授权文献
信息查询
